Nxstage medical, inc. (NXTM)
CashFlow / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-5,540

-15,224

-15,582

-15,325

-15,433

-7,429

-7,075

-7,317

-7,699

-8,811

-12,180

-16,260

-18,433

-23,265

-24,866

-24,313

-24,515

-22,667

-18,877

-18,561

-15,749

-13,345

-15,003

-15,153

-17,353

-20,049

-20,536

-21,402

0

0

0

Adjustments to reconcile net loss to net cash flow from operating activities:
Depreciation and amortization

34,063

33,862

33,591

33,754

33,984

33,826

33,368

32,637

31,449

30,891

30,771

30,715

30,642

29,827

28,786

27,697

26,713

25,932

25,359

24,848

24,608

24,352

24,033

23,673

23,167

23,208

23,117

23,087

0

0

0

Stock-based compensation

9,914

11,190

11,660

11,537

11,113

10,047

10,077

10,117

10,696

11,402

11,485

12,598

13,175

13,731

13,967

12,881

10,104

8,943

8,633

8,638

10,020

10,586

10,850

11,403

12,140

12,644

12,878

13,093

0

0

0

Other

-2,584

-3,556

-3,172

-2,131

-4,514

-2,795

-1,859

-2,445

332

72

-757

-1,302

-1,433

-2,240

-2,305

-1,877

-1,569

-1,852

-2,478

-2,628

-2,721

-2,398

-2,953

-3,517

-3,724

-3,672

-2,984

-3,064

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

31,599

-1,828

-5,509

-1,056

-556

1,801

10,450

7,388

71

3,795

4,981

1,130

3,694

-4,424

-932

4,188

4,676

10,169

3,141

1,095

2,861

3,143

4,434

3,141

2,112

1,871

2,885

1,773

0

0

0

Inventory

25,489

20,501

22,371

22,917

27,197

33,696

33,437

31,069

23,162

16,623

11,905

12,113

16,254

25,563

32,527

35,063

35,364

25,532

21,950

20,076

17,405

18,803

16,157

14,545

12,813

10,817

14,438

16,371

0

0

0

Prepaid expenses and other assets

1,847

0

1,054

1,045

85

490

756

68

-629

96

-523

77

1,286

1,495

1,740

2,214

-1,052

-1,550

-597

484

3,788

4,037

3,001

1,623

-192

1,115

1,263

1,491

0

0

0

Accounts payable

7,014

-60

-3,741

-22

-2,284

1,148

4,548

3,532

1,768

651

-3,241

-2,775

-9,122

-8,801

-4,264

-212

6,015

3,760

1,345

-2,233

1,751

3,740

4,995

839

-4,206

-7,464

-5,064

-1,047

0

0

0

Accrued expenses and other liabilities

6,593

3,641

1,388

-1,774

-160

1,706

1,115

4,141

3,714

2,947

2,240

635

2,204

993

1,416

4,235

6,895

3,557

958

1,081

-2,275

955

3,131

5,263

3,172

5,160

5,479

-324

0

0

0

Deferred revenues

27,827

-406

-1,345

-2,593

-3,425

-4,880

-4,448

-2,443

-3,073

-405

-851

-2,353

-123

-535

-486

-973

-234

-1,843

-4,010

-4,887

-6,250

-7,085

-4,631

-3,992

-3,117

-327

-202

1,648

0

0

0

Net cash provided by operating activities

23,520

17,886

11,227

4,802

1,583

1,226

-5,199

4,587

13,919

16,089

12,618

10,542

-1,458

-8,444

-16,477

-20,273

-12,441

-14,617

-8,608

-10,141

-9,228

-4,382

2,736

6,241

2,794

3,041

70

-1,516

0

0

0

Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired

-

-

-

-

-

-

-

513

513

513

513

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

6,008

6,502

8,681

9,194

9,602

8,315

7,093

8,848

11,180

12,822

12,872

11,537

13,870

15,596

17,207

20,097

19,259

19,560

19,138

16,246

12,109

9,109

8,153

7,694

7,778

7,110

6,097

5,156

0

0

0

Net cash used in investing activities

-6,008

-9,102

-11,281

-11,794

-12,202

-8,315

-7,093

-9,361

-11,420

-12,659

-12,709

-10,861

-13,467

-15,596

-17,207

-20,097

-19,259

-21,794

-21,372

-18,480

-14,343

-9,109

-8,153

-7,694

-7,778

-7,110

-6,097

-5,156

0

0

0

Cash flows from financing activities:
Issuance of shares under stock incentive plans, net of payroll taxes paid

3,051

5,532

6,993

12,003

13,336

12,218

10,842

5,994

6,697

6,586

5,590

6,663

11,241

10,497

10,640

11,133

5,974

5,837

6,213

5,484

2,763

3,849

3,864

5,248

7,024

7,723

8,629

7,965

0

0

0

Investment by noncontrolling interest holder

-

-

-

-

-

-

-

1,255

1,668

1,437

1,229

929

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,533

0

0

0

Repayments on loans and lines of credit

102

106

103

164

285

336

392

384

308

255

200

143

96

92

96

98

0

0

0

-

-

-

0

-

-

-

-

46

0

0

0

Repayments on capital leases

1,516

1,421

1,367

1,306

1,418

1,453

1,516

1,590

1,493

1,472

1,409

1,391

1,397

1,408

1,455

1,448

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,433

4,457

5,975

10,985

12,130

10,705

9,889

5,275

6,564

6,296

6,485

7,333

12,409

11,418

8,963

9,461

2,904

3,654

6,380

5,755

3,899

4,690

3,047

4,726

6,502

7,186

8,591

5,386

0

0

0

Foreign exchange effect on cash and cash equivalents

20

207

1,243

1,303

651

764

144

66

446

383

308

-833

-754

-1,107

-1,096

-341

215

539

626

561

152

239

-92

257

-86

-684

-229

-144

0

0

0

Increase in cash and cash equivalents

18,965

13,448

7,164

5,296

2,162

4,380

-2,259

567

9,509

10,109

6,702

6,181

-3,270

-13,729

-25,817

-31,250

-28,581

-32,218

-22,974

-22,305

-19,520

-8,562

-2,462

3,530

1,432

2,433

2,335

-1,430

0

0

0

Transfers from inventory to field equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Transfers from field equipment to deferred cost of revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0